Athira Pharma Inc [ATHA] Investment Appeal on the Rise
Athira Pharma Inc’s filing revealed that its Officer Mark James Litton acquired Company’s shares for reported $1.0 on Sep 05
Athira Pharma Inc’s filing revealed that its Officer Mark James Litton acquired Company’s shares for reported $1.0 on Sep 05
Starwood Property Trust Inc’s recent filing unveils that its President DiModica Jeffrey F. unloaded Company’s shares for reported $2.03 million
In a filing, Coty Inc revealed its Director Singer Robert S unloaded Company’s shares for reported $1.13 million on Mar
Fluence Energy Inc’s filing revealed that its Director BULLS HERMAN E acquired Company’s shares for reported $0.17 million on Aug
UiPath Inc’s recently made public that its Officer HITESH RAMANI acquired Company’s shares for reported $0.31 million on Oct 03
Hillenbrand Inc’s recent filing unveils that its Sr. VP, Operations COE & HOM Kulmaczewski Leo acquired Company’s shares for reported
In a filing, Carlyle Group Inc revealed its 10% Owner Carlyle Group Inc. unloaded Company’s shares for reported $0.56 million
Taking this into account, A number of analysts have revised their coverage, including National Bank Financial’s analysts, who increased its
Revance Therapeutics Inc’s recent filing unveils that its Chief Commercial Officer Jordan Erica unloaded Company’s shares for reported $9096.0 on
In a filing, Morgan Stanley revealed its Chief Human Resources Officer CRAWLEY MANDELL unloaded Company’s shares for reported $0.37 million
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.